Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Change in Account Payables (2016 - 2025)

Aethlon Medical filings provide 15 years of Change in Account Payables readings, the most recent being -$202334.0 for Q1 2025.

  • On a quarterly basis, Change in Account Payables fell 84.59% to -$202334.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $33131.0, a 90.03% decrease, with the full-year FY2025 number at $33131.0, down 90.03% from a year prior.
  • Change in Account Payables hit -$202334.0 in Q1 2025 for Aethlon Medical, up from -$229645.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $406264.0 in Q4 2023 to a low of -$229645.0 in Q4 2024.
  • Median Change in Account Payables over the past 5 years was $12870.0 (2022), compared with a mean of $26342.3.
  • Biggest five-year swings in Change in Account Payables: plummeted 2771.92% in 2021 and later skyrocketed 3056.67% in 2023.
  • Aethlon Medical's Change in Account Payables stood at -$3832.0 in 2021, then skyrocketed by 435.86% to $12870.0 in 2022, then skyrocketed by 3056.67% to $406264.0 in 2023, then crashed by 156.53% to -$229645.0 in 2024, then increased by 11.89% to -$202334.0 in 2025.
  • The last three reported values for Change in Account Payables were -$202334.0 (Q1 2025), -$229645.0 (Q4 2024), and $279026.0 (Q3 2024) per Business Quant data.